666 related articles for article (PubMed ID: 18054459)
1. Development and validation of a rapid RP-HPLC method for the determination of cetirizine or fexofenadine with pseudoephedrine in binary pharmaceutical dosage forms.
Karakuş S; Küçükgüzel I; Küçükgüzel SG
J Pharm Biomed Anal; 2008 Jan; 46(2):295-302. PubMed ID: 18054459
[TBL] [Abstract][Full Text] [Related]
2. Simple and reliable HPLC analysis of fexofenadine hydrochloride in tablets and its application to dissolution studies.
Oliveira DC; Weigch A; Rolim CM
Pharmazie; 2007 Feb; 62(2):96-100. PubMed ID: 17341026
[TBL] [Abstract][Full Text] [Related]
3. Determination of cetirizine dihydrochloride, related impurities and preservatives in oral solution and tablet dosage forms using HPLC.
Jaber AM; Al Sherife HA; Al Omari MM; Badwan AA
J Pharm Biomed Anal; 2004 Oct; 36(2):341-50. PubMed ID: 15496327
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a stability-indicating RP-HPLC method for the determination of paracetamol with dantrolene or/and cetirizine and pseudoephedrine in two pharmaceutical dosage forms.
Hadad GM; Emara S; Mahmoud WM
Talanta; 2009 Oct; 79(5):1360-7. PubMed ID: 19635371
[TBL] [Abstract][Full Text] [Related]
5. Method development and validation for the simultaneous determination of cetirizine dihydrochloride, paracetamol, and phenylpropanolamine hydrochloride in tablets by capillary zone electrophoresis.
Azhagvuel S; Sekar R
J Pharm Biomed Anal; 2007 Feb; 43(3):873-8. PubMed ID: 17023136
[TBL] [Abstract][Full Text] [Related]
6. Alternative and improved method for the simultaneous determination of fexofenadine and pseudoephedrine in their combined tablet formulation.
Maggio RM; Castellano PM; Vignaduzzo SE; Kaufman TS
J Pharm Biomed Anal; 2007 Dec; 45(5):804-10. PubMed ID: 17766076
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a HPLC method for the analysis of promethazine hydrochloride in hot-melt extruded dosage forms.
Thumma S; Zhang SQ; Repka MA
Pharmazie; 2008 Aug; 63(8):562-7. PubMed ID: 18771002
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a HPLC method for the determination of cetirizine in pharmaceutical dosage forms.
Paw B; Misztal G; Hopkała H; Drozd J
Pharmazie; 2002 May; 57(5):313-5. PubMed ID: 12061254
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a stability-indicating high performance liquid chromatographic (HPLC) assay for biperiden in bulk form and pharmaceutical dosage forms.
Mohammadi A; Mehramizi A; Moghaddam FA; Jabarian LE; Pourfarzib M; Kashani HN
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):152-7. PubMed ID: 17466605
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a HPLC method for the determination of buprenorphine hydrochloride, naloxone hydrochloride and noroxymorphone in a tablet formulation.
Mostafavi A; Abedi G; Jamshidi A; Afzali D; Talebi M
Talanta; 2009 Feb; 77(4):1415-9. PubMed ID: 19084658
[TBL] [Abstract][Full Text] [Related]
11. A simple and rapid high performance liquid chromatographic method with fluorescence detection for the estimation of fexofenadine in rat plasma--application to preclinical pharmacokinetics.
Pathak SM; Kumar AR; Musmade P; Udupa N
Talanta; 2008 Jul; 76(2):338-46. PubMed ID: 18585287
[TBL] [Abstract][Full Text] [Related]
12. Gradient HPLC-DAD determination of two pharmaceutical mixtures containing the antihistaminic drug ebastine.
Haggag RS; Belal TS
J Chromatogr Sci; 2012; 50(10):862-8. PubMed ID: 22677488
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a dissolution test for a once-a-day combination tablet of immediate-release cetirizine dihydrochloride and extended-release pseudoephedrine hydrochloride.
Likar MD; Mansour HL; Harwood JW
J Pharm Biomed Anal; 2005 Sep; 39(3-4):543-51. PubMed ID: 15975755
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a high-performance liquid chromatographic method for the determination of buspirone in pharmaceutical preparations.
Zaxariou M; Panderi I
J Pharm Biomed Anal; 2004 Apr; 35(1):41-50. PubMed ID: 15030878
[TBL] [Abstract][Full Text] [Related]
15. Isocratic RP-HPLC method for rutin determination in solid oral dosage forms.
Kuntić V; Pejić N; Ivković B; Vujić Z; Ilić K; Mićić S; Vukojević V
J Pharm Biomed Anal; 2007 Jan; 43(2):718-21. PubMed ID: 16920326
[TBL] [Abstract][Full Text] [Related]
16. Stability indicating method for famotidine in pharmaceuticals using porous graphitic carbon column.
Helali N; Monser L
J Sep Sci; 2008 Feb; 31(2):276-82. PubMed ID: 18172920
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a reversed-phase ion-pair high-performance liquid chromatographic method for the determination of risedronate in pharmaceutical preparations.
Kyriakides D; Panderi I
Anal Chim Acta; 2007 Feb; 584(1):153-9. PubMed ID: 17386598
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a reversed-phase HPLC method for simultaneous estimation of ambroxol hydrochloride and azithromycin in tablet dosage form.
Shaikh KA; Patil SD; Devkhile AB
J Pharm Biomed Anal; 2008 Dec; 48(5):1481-4. PubMed ID: 18993009
[TBL] [Abstract][Full Text] [Related]
19. Determination and quantification of cetirizine HCl in dosage formulations by RP-HPLC.
Arayne MS; Sultana N; Siddiqui FA
Pak J Pharm Sci; 2005 Jul; 18(3):7-11. PubMed ID: 16380337
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of RP-HPLC method to determine letrozole in different pharmaceutical formulations and its application to studies of drug release from nanoparticles.
Mondal N; Pal TK; Ghosal SK
Acta Pol Pharm; 2009; 66(1):11-7. PubMed ID: 19226963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
